Antibiotice SA ATB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 4.25
- Price/Sales
- 2.13
- Dividend Yield (Trailing)
- 0.43%
- Dividend Yield (Forward)
- 0.43%
- Total Yield
- 0.43%
Company Profile
Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,352
- Website
- http://www.antibiotice.ro
Comparables
Valuation
|
Metric
|
ATB
|
603367
|
002826
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.25 | 15.10 | 30.99 |
Price/Book Value | 1.51 | 1.20 | 2.02 |
Price/Sales | 2.13 | 1.53 | 1.84 |
Price/Cash Flow | 12.02 | 16.86 | 26.98 |
Price/Earnings
ATB
603367
002826
Financial Strength
|
Metric
|
ATB
|
603367
|
002826
|
|---|---|---|---|
Quick Ratio | 1.27 | 2.87 | 2.08 |
Current Ratio | 2.11 | 3.74 | 2.40 |
Interest Coverage | 23.08 | 75.98 | 35.08 |
Quick Ratio
ATB
603367
002826
Profitability
|
Metric
|
ATB
|
603367
|
002826
|
|---|---|---|---|
Return on Assets (Normalized) | 8.21% | 6.25% | 5.08% |
Return on Equity (Normalized) | 11.05% | 7.93% | 6.75% |
Return on Invested Capital (Normalized) | 10.41% | 7.24% | 6.29% |
Return on Assets
ATB
603367
002826
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Nwyywthjw | Mbvbt | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Dccmhxyypd | Zfhry | $68.1 Bil | |
HLN
| Haleon PLC ADR | Tfghywjt | Gcw | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dhxpzlgp | Knpkx | $14.3 Bil | |
VTRS
| Viatris Inc | Zvrkhtk | Blm | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Czddsmrxx | Fxy | $12.0 Bil | |
CTLT
| Catalent Inc | Gdvdcyls | Bzsyfx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Krllklzg | Wrbs | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gxytxjb | Nns | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ymdsbfcdr | Swbdt | $3.4 Bil |